Rahul Palchaudhuri
About Rahul Palchaudhuri
Rahul Palchaudhuri serves as the Executive Director at Tessera Therapeutics, having previously held senior roles at Magenta Therapeutics. He holds a PhD in Chemistry and has extensive experience in biology and biotherapeutics, with a background in hematology research.
Current Role at Tessera Therapeutics
Rahul Palchaudhuri serves as the Executive Director at Tessera Therapeutics, a position he has held since 2023. He works on-site in Somerville, Massachusetts. In this role, he is involved in advancing the company's initiatives in genetic medicine and therapeutic development.
Previous Experience at Magenta Therapeutics
Prior to his current role, Palchaudhuri held multiple positions at Magenta Therapeutics. He served as Senior Director of Biology and Biotherapeutics for three months in 2022. He was also the Vice President of Research from 2022 to 2023 and worked as Program and Research Lead for anti-CD45 Antibody Drug Conjugate from 2021 to 2023. His contributions included leadership in research and development efforts.
Educational Background and Expertise
Palchaudhuri has an extensive educational background in the sciences. He earned a Doctor of Philosophy (Ph.D.) in Chemistry from the University of Illinois Urbana-Champaign, where he studied from 2005 to 2011. He also holds a Bachelor of Arts in Chemistry from Grinnell College, completed in 2005. Additionally, he achieved a Postdoctoral Fellowship in Hematology at Harvard University, where he worked from 2011 to 2016.
Research Contributions and Presentations
Palchaudhuri has made significant contributions to the field of gene therapy, particularly in the area of RNA delivery. He presented on in vivo RNA delivery to T cells and hematopoietic stem cells using targeting lipid nanoparticles at the American Society of Gene and Cell Therapy's 27th Annual Meeting. His research focuses on innovative approaches to enhance therapeutic efficacy.